Moderna Stock Jumps on Surprise Profit, Sales Ahead of Expectations
Vaccine maker Moderna reported a profit of 55 cents a share on revenue of $2.8 billion in the December quarter, beating analysts’ expectations.
Stay updated with breaking news from Merck Amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vaccine maker Moderna reported a profit of 55 cents a share on revenue of $2.8 billion in the December quarter, beating analysts’ expectations.
Merck posted a 3-cent a share profit in the fourth quarter, beating expectations of a loss.
Apple, Amazon.com, and Meta Platforms are scheduled to report quarterly earnings after the closing bell Thursday, Align Technology issues a strong revenue...
Alaska Air and United Airlines resume flying Boeing 737 MAX 9 jets, Chinese property developer Evergrande Group is ordered to liquidate, and SoFi...
While the S&P 500 rose 24% in 2023, the S&P 500 Pharmaceuticals industry index slipped 2.2%. Lilly and Novo Nordisk were the exceptions in a slumping...